Mu Investments Co., Ltd. Amgen Inc Transaction History

Mu Investments Co., Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 Apr 20, 2018	SELL	$169.43 - $198.0 $44,051 - $51,480	-260 Closed	0 $0
Q4 2017 Jan 17, 2018	SELL	$168.79 - $188.59 $16,879 - $18,859	-100 Reduced 27.78%	260 $46,000
Q3 2017 Oct 17, 2017	BUY	$167.29 - $191.0 $60,224 - $68,760	360	360 $67,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Mu Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mu Investments Co., Ltd. with notifications on news.